CIMZIA

UCB Canada Inc🇨🇦 Health Canada

Approval Id: 7d586043bfcfda3a
Drug Approval Canada Name: CIMZIA
Product Name: CIMZIA
Status: Marketed
Status Date: 2017-08-04
Original Market Date: 2017-08-04
Din: 02465574
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 90:24.16.92
Atc Original: L04AB05 CERTOLIZUMAB PEGOL
Atc Name: l 04 ab 05
Aig Number: 0152646001
Company Name: UCB Canada Inc
Company Address: 602, 2201 Bristol Circle, Oakville, Ontario, Canada, L6H 0J8

CERTOLIZUMAB PEGOL

200 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

7d586043bfcfda3a

Type

Standard